Search
for
Sort by
Research 91–120 of 1000+
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Clinical use of 5α-reductase inhibitors
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase
- 705 Influence of 5a-Reductase Inhibitor (5-ARI) Usage on the Reproductive Function of Married Men
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Estudio comparativo de dos complementos alimenticios inhibidores de la 5a-reductasa en la alopecia androgénica femenina
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- ABSTRACTS—SYMPOSIA
- Androgenetic alopecia in men and women
- Finasteride: A slow-binding 5.alpha.-reductase inhibitor
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- 9 Role of 5α-reductase in health and disease
- 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives
- Is There an Association between 5a Reductase Inhibitors and Metabolic Syndrome? A Narrative Review of the Literature
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review